Alterations in intracellular calcium during sepsis

Indian Journal of Physiology and Pharmacology

Volumn 41, Issue 4, 1997, Pages 344-352

  Bhattacharyya, Jharna ^a   Sayeed, Mohammed M ^b  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ca2+; Cytokine; Diltiazem; Sepsis; Soleus muscle

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; DILTIAZEM; NIFEDIPINE; TUMOR NECROSIS FACTOR; VERAPAMIL;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; GRAM NEGATIVE BACTERIUM; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEPSIS; SKELETAL MUSCLE; TISSUE INJURY;

ADJUVANTS, IMMUNOLOGIC; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYTOKINES; HUMANS; SEPSIS; WOUNDS AND INJURIES;

EID: 0030669527     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Winegrad S. Electrochemical coupling in the heart muscle. In Berne RM and Sperelakis N eds. Handbook of physiology, Sec.2, Md. Bethesa, American Physiological Society, 1979, 393-428.
2. Williamson JR, Cooper RH, Hock JB. Role of calcium in the hormonal regulation of liver metabolism. Biochem Biophys Acta 1981; 639; 242-295.
3. Dedman JR, Brinkley BR, Means AR. Regulation of microfilaments and microtubules by calcium and cyclic AMP. Adv Cycl Nucleot Res. 1979; 11:131-174.
4. Rasmussen H, Barret PQ. Calcium messenger system : an integrated view. Physiol Rev 1984; 64:938-984.
5. Rasmussen H. The calcium messenger system. N Engl J Med 1986; 314:1094-1101.
6. Dedman JR. Mediation of intracellular calcium : variances on a common theme. Cell Calcium 1986; 7:297-307.
7. Hutton JC. Calcium binding proteins and secretion. Cell Calcium 1986; 7:339-359.
8. Nicholls DG. Intracellular calcium homeostasis. Br Med Bull 1986; 42:353-358.
9. Berridge MJ. Inositol triphosphate and diacylglycerol, two interacting second messengers. Annu Rev Biochem 1987; 56:159-193.
10. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem 1987; 56:395-433.
11. Mean AR, Chafouleas JG, Tash JG. Physiological implications of the presence, distribution and regulation of calmodulin in eukaryotic cells. Physiol Rev 1982; 62:1-39.
12. Martonosi A. Muscle and non-muscle motility. In Stracher A ed. Acad. Press, New York, Vol I, 1983, 233-357.
13. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischemic injury. N Engl J Med 1986; 34:1069-1076.
14. Westfall MV, Sayeed MM. Skeletal muscle calcium uptake in bacteremic rats. Am J Physiol 1989; 256: R201-R206.
15. Westfall MV, Sayeed MM. Effect of diltiazem on skeletal muscle 3-O-methylglucose transport in bacteremic rats. Am J Physiol 1989; 256:R7l6-R721.
16. Bhattacharyya J, Thompson KD, Sayeed MM. Skeletal muscle calcium flux and catabolic response during sepsis. Am J Physiol 1993; 265:R487-R493.
17. Bhattacharyya J. Thompson KD, Sayeed MM. Calcium-dependent and calcium-independent protease activities in skeletal muscle during sepsis. Circ Shock 1991; 35:117-122.
18. Muallem S. Calcium transport by resting and stimulated cells. In Brunner F ed. Intracellular calcium regulation. Wiley-Liss New York, 1990; 349-380.
19. 2+ : A critical link in the pathophysiology of sepsis. Proc Natl Acad Sci 1993; 91:3039-3043.
20. Hotchkiss RS, Karl IE. Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Proc Natl Acad Sci 1994; 91:3039-3049.
21. 2+ regulation in the liver in endotoxic shock. Am J Physiol 1986; 250:R884-R891.
22. 2+ and glycogen phosphorylase in endotoxicosis and sepsis. Am J Physiol 1986; 251:R984-R995.
23. 2+ mobilization in hepatocytes during endotoxic shock. Am J Physiol 1987; 253:R545-R548.
24. 2+ regulation during endotoxic shock. Am J Physiol 1987; 253:R549-R554.
25. Spitzer JA, Deaciuc IV. Effect of endotoxicosis and sepsis on intracellular uptake. Circ Shock 1986; 18:81-93.
26. 2+ release in permeabilized hepatocytes of endotoxemic and septic rats. Am J Physiol 1987; 253:E130-E134.
27. 2+ signalling and proliferative response during sepsis. Shock 1994; 1:466-471.
28. Fleckenstein A. Calcium antagonism in heart and smooth muscle experimental facts and therapeutic prospects. New York : Willey Interscience, 1983.
29. Lee KS, Tsien RW. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialyzed heart cells. Nature 1983; 302:790-794.
30. 2+ channels. Biochem Pharmacol 1986; 35: 3045-3052.
31. Flaim SF. Comparative pharmacology of calcium blockers based on studies of vascular smooth muscle, in Flaim SF, Zelis R eds, Calcium, blockers Baltimore Munich : Urban and Schwarzenberg, 1982; 155-178.
32. Emery AEH, Burt D. Intracellular calcium and pathogenesis in antinatal diagnosis of Duchenne Muscular Dystrophy. Br Med J 1980; 28O: 355-357.
33. Fingerman E, Campisi J, Pardee AB. Defective calcium metabolism in Duchennal muscular dystrophy : Effects of cellular and viral growth. Proc Natl Acad Sci 1984; 81:7617-7621.
34. Turner PA, Westwood T, Regan M, Steinhardt RA. Increased protein degradation results from elevated calcium levels found in muscle from mdx mice. Nature 1988; 335: 735-738.
35. 2+ flux during sepsis. FASEB J 1990; 4:A1088.
36. Martonosi A. Calcium regulation in muscle diseases; the influence of innervation and activity. Biochem Biophys Acta 1989; 991:155-242.
37. Bhattacharyya J, Ahmad S, Sayeed MM. In Mallick BN and Singh R eds. Environment and Physiology 1990; Narosa Publication 122-130.
38. Bhattacharyya J. Protein catabolic response and proteases during pathophysiological injury of skeletal muscle. Indian J Physiol Allied Sci 1995; 49:59-67.
39. Trumpf BF, Berezesky IK. Calcium mediated cell injury and cell death. FASEB J 1995; 9:219-228.
40. Duncan CG. Role of intracellular calcium in promoting muscle damage : a strategy for controlling the dystrophic condition. Experientia 1978;34:1531-1535.
41. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis : mechanism of endotoxin resistance. Science 1986; 232:977-980.
42. Tracey KJ, Beutler B, Lowry SE, Merry-weather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires FT, Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-474,
43. Gaskill HV III. Continuous infusion of interferon tumor necrosis factor : mechanisms of toxicity in the rat. J Surg Res 1988; 44:664-671.
44. Tracey KJ, Fong Y, Hesse DG, Manague KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330:662-664.
45. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229:869-871.
46. 2 production by trauma patients' monocytes. Arch Surg 1990; 125:29-35.
47. Filkins JP. Monokines and the metabolic pathophysiology of septic shock. Fed Proc 1985; 44:300-304.
48. Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6:51-95.
49. Dinanello CA, Meir JW. Current concepts-Lymphokines. N Engl J Med 1987; 317:340-345.
50. 2 release by leucocytic pyrogen (Interleukin-1) : A mechanism for increased degradation of muscle proteins during fever. N Engl J Med 1983; 308 : 553-558.
51. Moldawer LL, Svaninger G, Gelin J, Lundhoim KG. Interleukin-1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am J Physiol 1987; 253:766.
52. Evaerdt B, Brouckaert P, Shaw A, Fiers W. Four different interleukin-1 species sensitize to the lethal action of tumor necrosis factor. Biochem Biophys Res Commun 1989; 163:378-385.
53. 2 production by Interleukin-1. In Kluger MJ, Oppenheim JJ and Powanda MC eds., The Physiologic, Metabolic and Immunologic Actions of Interleukin-1. Alan R Liss Inc 1985; 193-200.
54. Berczi I. Neuroendocrine defence in endotoxic shock. Acta Mirobiol Hung 1993; 40:265-302.
55. Watson RWG, Redmond HP, Bouchier-Heyes D. Role of endotoxin in mononuclear phagocytemediated inflammatory responses. J. Leukoc Biol 1994; 56:95-103.
56. Dunn AG, Chuluyan HE. Endotoxin elicits normal tryptophan and indolamine responses but impaired catecholamine and pituitary-adrenal responses in endotoxin-resistant mice. Life Sci 1994; 54:847-853.